Mary Hesdorffer, MS, NP, of the Meso Foundation and Lee Krug, MD, of the Memorial Sloan-Kettering Cancer Center moderate a panel at the 2014 International Symposium on Malignant Mesothelioma on novel therapeutics and clinical trials. Presenters include Dirk Brockstedt, PhD, of Aduro BioTech, Inc., Mitchell Keegan, PhD, of Verastem, and Andrew Haas, MD, PhD, of the University of Pennsylvania.
No comments:
Post a Comment